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ABSTRACT
Among the most readily available chemical warfare agents, sulfur mustard (SM), also known as mustard gas, has been the most 
widely used chemical weapon. SM causes debilitating effects that can leave an exposed individual incapacitated for days to months; 
therefore delayed SM toxicity is of much greater importance than its ability to cause lethality. Although not fully understood, acute 
toxicity of SM is related to reactive oxygen and nitrogen species, oxidative stress, DNA damage, poly(ADP-ribose) polymerase (PARP) 
activation and energy depletion within the affected cell. Therefore several antioxidants and PARP inhibitors show beneficial effects 
against acute SM toxicity. The delayed toxicity of SM however, currently has no clear mechanistic explanation. One third of the 100,000 
Iranian casualties are still suffering from the detrimental effects of SM in spite of the extensive treatment. We, therefore, made an 
attempt whether epigenetic aberrations may contribute to pathogenesis of mustard poisoning. Preliminary evidence reveals that 
mechlorethamine (a nitrogen mustard derivative) exposure may not only cause oxidative stress, DNA damage, but epigenetic pertur-
bations as well. Epigenetic refers to the study of changes that influence the phenotype without causing alteration of the genotype. 
It involves changes in the properties of a cell that are inherited but do not involve a change in DNA sequence. It is now known that 
in addition to mutations, epimutations contribute to a variety of human diseases. Under light of preliminary results, the current 
hypothesis will focus on epigenetic regulations to clarify mustard toxicity and the use of drugs to correct possible epigenetic defects. 
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melphalan and chlorambucil are valuable cytotoxic and 
radiomimetic agents for the treatment of cancer (Kehe and 
Szinicz, 2005). 
Proposed mechanism of acute toxicity
SM is absorbed by inhalation or through the skin following 
exposure. Potent alkylating activity is not a result of mus-
tards themselves but is due to their derivatives including 
sulfonium and carbonium for SM, and aldophosphamide 
and acrolein for CP. These derivatives are also responsible 
for the side effects of chemotherapeutic mustards. After 
absorption, SM undergoes intramolecular cyclization to 
form  a  sulfonium  or  carbonium  intermediate.  This,  in 
turn, reacts with and alkylates nucleic acids and proteins, 
resulting in impaired cell homeostasis and eventual cell 
death. Oxidative and nitrosative stress contribute to the 
early effects of SM poisoning. It typically affects 3 major 
organ systems: skin, lungs, and eyes. When absorbed in 
large amounts it can also damage rapidly proliferating cells 
Introduction 
Among the available chemical warfare agents, sulfur mus-
tard (SM), also known as mustard gas, has been a widely used 
chemical weapon. Because of its devastating toxicity, its use 
during the World War I earned it the sobriquet “king of the 
battle gasses”. Other compounds such as nitrogen mustard 
(HN2) were developed during World War II, but found to 
be unsuitable as a munition (Smith and Skelton, 2003; Kehe 
and Szinicz, 2005). Soon after discovering HN2, it became 
the first non-hormonal agent used in cancer chemotherapy. 
A number of nitrogen mustard derivatives such as cyclo-
phosphamide  (CP),  ifosfamide  (IF),  mechlorethamine, 
oRIGINAL ARTICLe237
Also available online on setox.eu/intertox
Interdisciplinary Toxicology. 2008; Vol. 1(3–4): 236–241
Copyright © 2010  Slovak Toxicology Society SETOX
of the bone marrow and cause severe suppression of the 
immune system, as well as other systemic toxicities such as 
neurologic and digestive disorders.
After several decades of research it was revealed that CP 
and other toxic agents share most of the same pathophysi-
ologic mechanisms (Korkmaz et al., 2006; Korkmaz et al., 
2007). Recent data consistently proves that reactive oxygen 
species (ROS) (Yildirim et al., 2004; Ozcan et al., 2005; Sadir 
et al., 2007) as well as reactive nitrogen species (RNS), for 
instance excessive amounts of nitric oxide (NO) produced 
by  inducible  nitric  oxide  synthase  (iNOS)  (Korkmaz  et 
al., 2003; Oter et al., 2004; Topal et al., 2005; Ucar et al., 
2007), involve in initial detrimental effects of all mustards. 
Currently, available knowledge supports the idea that a 
major cause of the toxicity of SM as well as other mustards 
is the formation of enormous amounts of the highly toxic 
reactant, peroxynitrite (ONOO−), (Korkmaz et al., 2005; 
Yaren et al., 2007). Thus, both oxidative and nitrosative 
(nitro-oxidative) stress take place in pathophysiology of 
acute mustard toxicity. 
A direct toxic effect of ONOO− at the site of its produc-
tion involves an intriguing process which decides the fate of 
cells. ONOO– is per se not a radical but is a powerful nitro-
sating agent. ONOO– interacts with and covalently modifies 
all major types of biomolecules including membrane lipids, 
thiols, proteins and DNA (Demicheli et al., 2007; Pacher 
et al., 2007). ONOO− activates matrix metalloproteinases 
(MMPs) (Okamoto et al., 2001; Wu et al., 2001) and triggers 
the expression of selectins and cellular adhesion molecules, 
via enhancing of NF-κB activation (Szabo 2003), thereby 
promoting pro-inflammatory responses. 
The mutagenic properties of ONOO−-induced modified 
products have also been determined (Juedes and Wogan, 
1996; Whang et al., 1998). Several studies have shown that 
NO itself does not induce DNA single-strand breaks in vitro 
in plasmid DNA (Tamir et al., 1996; Masuda et al., 2002), 
whereas exposure of plasmid DNA to pre-formed ONOO− 
(Yoshie and Ohshima 1997) or NO plus O2
•− generated 
concurrently (Chaturvedi et al., 1998) induces DNA strand 
breaks. Single strand breakage can be induced by treatment 
with very low concentrations of ONOO− indicating that this 
agent is a potent inducer of this type of damage to DNA 
(Yermilov et al., 1996). These observations suggest addi-
tional pathways by which ONOO− may be associated with 
not only elevated DNA damage but also impairment of DNA 
repair capacity (Chien et al., 2004). ONOO− induces apop-
tosis and necrosis in cells. More highly elevated exposure of 
this agent is associated with necrosis rather than with apop-
tosis (Szabo, 2003; Virag et al., 2003). In this mechanism, 
activation of the DNA repair enzyme poly(ADP-ribose) 
polymerase-1 (PARP-1), a member of PARP enzyme family, 
mediates ONOO−-induced necrosis. PARP-1 detects and 
signals DNA strand breaks induced by a variety of geno-
toxic insults. Upon binding to DNA, strand breaks occur 
and, PARP transfers ADP-ribose units from the respiratory 
coenzyme nicotinamide adenine dinucleotide (NAD+) to 
various nuclear proteins. From a physiological view point, 
PARP-1 activity and poly(ADP-ribosyl)ation reactions are 
implicated in DNA repair processes, the maintenance of 
genomic  stability,  the  regulation  of  gene  transcription, 
and DNA replication. An important function of PARP-1 
is to allow DNA repair and cell recovery under conditions 
associated with a low level of DNA damage. In case of severe 
DNA injury, overactivation of PARP-1 depletes the cellular 
stores of NAD+, an essential cofactor in the glycolytic path-
way, the tricarboxylic acid cycle, and the mitochondrial 
electron transport chain. As a result, the loss of NAD+ leads 
to a marked reduction in the cellular pools of ATP, result-
ing in cellular dysfunction and cell death via the necrotic 
pathway (Szabo, 2003; Virag et al., 2003). This is known as 
“suicide hypothesis” of PARP activation and seems to be a 
regulatory mechanism to eliminate cells after irreversible 
DNA injury. Experimental evidence has established that the 
PARP-1 pathway of cell death plays a pivotal role in tissue 
injury and organ dysfunction in CP-and SM-induced toxic-
ity (Kehe et al., 2008; Korkmaz et al., 2008b). Cells that are 
intoxicated by SM and are repaired by the PARP-1 seem to 
be responsible of the delayed toxicity. These cells should be 
free of major DNA damage, are able to divide but they also 
have either light to mild but not severe DNA damage and/or 
other type of damages. 
Unfortunately, it is not clear how mustard gas causes 
severe multi-organ damage years after even a single expo-
sure. It is well known that most metabolites of mustard 
agents are excreted in the urine within a few weeks after 
exposure (Somani and Babu, 1989). It is also well docu-
mented that mustard analogues such as CP and IF severely 
damage DNA and other molecules, and have toxicity long 
after  the  initial  exposure  leading  to  cell  death  and  an 
increased likelihood of cancers (Smith et al., 2003). As noted 
above, the initial toxicity of mustards relates to a massive 
onslaught of highly reactive oxidizing and nitrosating mol-
ecules. For most mustard agents, once these changes occur 
the cellular effects essentially disappear. For SM, however, 
there are delayed progressive effects which render victims 
incapacitated for years (Balali-Mood et al., 2005; Hefazi et 
al., 2005; Mahmoudi et al., 2005; Balali-Mood and Hefazi, 
2006; Shohrati et al., 2007). The pathophysiologic mecha-
nism of delayed mustard gas toxicity currently has no clear 
mechanistic explanation. 
Epigenetic perturbations; possible 
explanation of SM-induced delayed toxicity
If the nuclear DNA in a cell is damaged, it is either repaired 
via several means including DNA repair enzymes (Nohmi 
et al., 2005) or the cell eventually dies (Szabo et al., 2001; 
Szabo, 2003). However, if SM causes not only genotoxicity 
but also it alters epigenetic processes, this could explain, at 
least in part, the delayed effects of this warfare agent. We 
propose that, the epigenetic regulation of the DNA may be 
the underlying mechanism of delayed effects of SM (Bird, 
2002; Lyko and Brown, 2005). 
A genetic change is thought of as a permanent, inheritable 
change affecting every cell if it is passed along through the 
germline. However, these assumptions are not totally cor-
rect. In addition to the DNA inheritance system underlying 238
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classical genetics, it is now recognized that variations can be 
transmitted between generations in other ways; the epigen-
etic inheritance system (EIS). The traditional view that gene 
and environment interactions control disease susceptibility 
can now be expanded to include epigenetic reprogram-
ming as a key determinant of origins of human disease 
(Bronner et al., 2007). The term epigenetic describes the 
study of heritable alterations in gene expression that occur 
in the absence of changes in genome sequence. This can be 
contrasted with genetics, which deals with the transmis-
sion of information based on differences in DNA sequence. 
Therefore, epigenetic gene regulation requires molecular 
mechanisms that encode information in addition to the 
DNA base sequence and can be propagated through mitosis 
and meiosis. Our current understanding of epigenetic gene 
regulation involves two classes of molecular mechanisms: 
DNA methylation and histone modifications (Bestor, 2000; 
Yang and Seto, 2007). 
The chromatin structure is influenced by DNA meth-
ylation and DNA-histone interactions. The DNA-histone 
interaction is further influenced by covalent modification 
of histones and the action of DNA-binding proteins. The 
epigenotype can be transmitted from parent cell to daughter 
cell maintaining a specific epigenotype within cell lineages. 
Thus, the phenotype is a result of the genotype, the specific 
DNA sequence, and the epigenotype. The genotype must 
exist in a particular chromatin configuration, the epigeno-
type, which allows a secondary level of fine control over 
gene expression. EIS is generally accepted less stable than 
the genetic system, and more sensitive to environmental 
(McLachlan 2001), nutritional (Gallou-Kabani and Junien, 
2005)  and  chemical  toxicants  (McLachlan  et  al.,  2001; 
Bombail et al., 2004). Epigenetic memory of cells can be 
passed on to subsequent generations and can transfer the 
perturbed epigenome upon unaffected or normal genetic 
sequences. The epigenotype shows far greater plasticity 
than the genotype, and it has been speculated that epigen-
etic errors could be a major contributor to human diseases 
(Jiang et al., 2004).
A variety of enzymes are involved in this process includ-
ing most importantly DNA methyltransferases (DNMTs), 
histone acetyl transferases (HATs) and histone deacetylases 
(HDACs) (Miremadi et al., 2007). Indeed, the transcrip-
tional status of all genes (silent, repressed or active) is deter-
mined by its chromatin environment and many molecular 
responses to toxicants involve alterations in gene expression 
that are elicited via changes in the chromatin structure of 











ACTIVATION OF GENE EXPRESSION
Figure 1. Our current understanding of epigenetic gene regulation involves basically two classes of molecular mechanisms: DNA methylation 
and histone modifi  cations. A variety of enzymes are involved in this process including most importantly DNA methyltransferases (DNMTs), histone 
deacetylases (HDACs) and histone acetyl transferases (HATs). Indeed, the transcriptional status of all genes (silent, repressed or active) is determined 
by its chromatin environment and many molecular responses to toxicants involve alterations in gene expression that are elicited via changes in the 
chromatin structure of target genes. The steady state level of histone acetylation is regulated by the HATs and HDACs. HATs are responsible for the 
addition of acetyl groups that stabilize open chromatin structures, while the HDACs deacetylate histones, and are thus responsible for resetting chro-
matin into a close conformation. DNA methylation is mediated by several proteins. DNMTs add methyl groups to the cytosines in CpG dinucleotides. 
Three active DNMTs have been recognized in humans and are designated DNMT1, DNMT3a, and DNMT3b. Each DNMT may have a specifi  c role in 
the methylation process, or may act in association with another methyltransferase. Open chromatin is considered as transcriptionally active, whereas 
condensed chromatin is transcriptionally inactive. 239
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Since the genome contains information in two forms, 
genetic  and  epigenetic,  become  clear,  initial  studies 
focused on human cancers and rapidly revealed that most 
of human cancers are relevant to epigenetic aberrations 
(i.e., epimutations) (Ducasse and Brown, 2006) including 
epigenetic silencing (Robertson, 2001) of tumor suppres-
sor genes because of hypermethylation (Esteller, 2007). To 
date, numerous tumor suppressor genes have been found to 
undergo hypermethylation in cancer (Garinis et al., 2002; 
Das and Singal, 2004). Such epimutations rarely appear in 
healthy tissue, indicating that epigenetic therapies may have 
high tumor specificity. Currently, two DNMT inhibitors 
(DNA demethylating drugs) received US Food and Drug 
Administration approval for the treatment of myelodys-
plastic syndrome: 5-azacytidine (Vidaza®) and its derivative 
decitabine (Dacogen®) are now being marketed (Brueckner 
et al., 2007) and several presently available drugs are under 
extensive clinical investigations (Peedicayil, 2006). 
Exposure to mustards may trigger a variety of mecha-
nisms along with nitro-oxidative stress, inflammation and 
DNA damage. If this is the case, a number of drugs (e.g., 
anti-oxidants, anti-inflammatory agents) in treatment of 
experimental toxicity may not be beneficial for victims. 
Data based on the experience in Iranian veterans exposed 
to the agent during the Iran-Iraq conflict (1983–88) have 
clearly shown that toxicity of SM is almost incurable even 
extensive treatments (Balali-Mood and Hefazi, 2005). It was 
described that the toxic effects of SM poisoning in a group 
of 40 severely intoxicated Iranian veterans, 16–20 years after 
their initial exposure. The most commonly affected organs, 
in this study, were lungs (95%), skin (75%) and eyes (65%) 
(Balali-Mood et al., 2005). Another clinical study revealed 
that the delayed toxicity of SM persists on the respiratory 
tract (78%), central nervous system (45%), skin (41%) and 
eyes (36%) in 236 Iranian veterans in between 2 and 28 
months after exposure (Balali-Mood and Hefazi, 2006). In 
Control Mechloretamine
Trichostatine - A (HDAC inhibitor) Decitabine (DNMT inhibitor)
Figure 2. Representative histological pictures of the preliminary study groups. Normal lung tissue of rat (control). Alveolar cavities are normal; there 
is no edema and hemorrhage (control). In MEC group, interstitial edema and some hemorrhage are seen in several areas. Inflammatory cell infiltra-
tion is present in the alveolar cavity, mucosal epithelium and airways. Administration of HDAC inhibitor alleviated the MEC symptoms. The alveolar 
cavities, vascular bed and airways are relatively normal. In the representative figure of the DNMT inhibitor group interstitial edema and hemor-
rhage as well as septal thickening is apparent in many areas. Many airways are larger than those of the control group and similar to MEC group   
(Hematoxylin & Eosin × 40).240
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a study by Khateri et al., (2003) on 34,000 Iranians, 13–20 
years after exposure to SM, the most common complica-
tions were still found in the lungs (42.5%), eyes (39%), and 
skin (24.5%) (Khateri et al., 2003). Although, a vast array of 
experimental remedies, there is no consensus on medical 
management of victims exposed to mustard gas, other than 
thorough decontamination and supportive care. Therefore, 
this paucity of information regarding the medical manage-
ment warrants novel approaches to the pathogenesis of 
SM poisoning. We recently reviewed the possible epigenitc 
mechanisms involved in the pathogenesis of mustard toxic-
ity (Korkmaz et al., 2008a). 
Preliminary study of the hypothesis
The experimental protocol was approved by the animal 
ethical committee of Gulhane Military Medical Academy. A 
total of 40 male SD rats were divided into 4 groups. Group 1 
served as control and given 2 ml saline, three groups received 
single dose of mechlorethamine (MEC) (3.5 mg/kg subcu-
taneously) with the same time intervals. Group 2 received 
MEC only; group 3 received histone deacetylase (HDAC) 
inhibitor  (Trichostatine  A,  Sigma  Germany)  (1 mg/kg) 
and group 4 received DNA methyl transferase (DNMT) 
inhibitor (decitabine, Sigma Germany) (0.02 mg/kg), intra-
peritoneally. MEC injection resulted in severe lung toxicity 
with strong interstitial and alveolar edema, hemorrhage, 
emphysematous changes as well as mild inflammatory cell 
infiltration and septal thickening. In group 3, the HDAC 
inhibitor  significantly  reduced  interstitial  and  alveolar 
edema, hemorrhage and inflammatory cell infiltration. On 
the other hand, we have observed severe lung damage by 
using DNMT inhibitor (group 4). In HDAC inhibitor group, 
the results were close to sham group. In DNMT inhibitor 
group, however, histology of lungs was worse than MEC 
group results (Figure 2).
These preliminary results revealed that, MEC itself and/
or its intracellular metabolites perturb the epigenetic envi-
ronment of the affected cell in lung tissue. Hypothetically, 
MEC may cause HDAC induction leading to a variety of gene 
silencing. Since the animals were healthy and free of disease, 
inhibiting HDAC by Trichostatine A means that, mustards 
may activate HDAC which results in silencing a variety 
of beneficial genes which code, for example, anti-oxidant 
enzymes and anti-inflammatory proteins. Since decitabine 
worsen the MEC-induced lung injury, inhibition of DNMT 
may silence the genes those are physiologically silenced but 
require methylation to be activated. Although these genes 
have normally lower activation level or totally inactive, any 
proper stimulus can cause gene activation. From this man-
ner, it seems logical that, by inhibiting DNMT, we may block 
gene expression such as anti-oxidant enzymes and anti-
inflammatory proteins. If this mechanism is true, inhibiting 
HDAC may block the silencing of beneficial genes, on the 
contrary inhibiting of DNMT may result the silencing of the 
same group genes. Further studies are needed to clarify the 
involvement of epigenetic perturbations in the pathogenesis 
of mustard toxicity.
Concluding remarks
It seems that epigenetic modifiers have influence on gene 
expression in the pathogenesis of mustard-induced lung 
toxicity. Epigenetic therapy is a new and rapidly developing 
area in pharmacology. To date, most trials of epigenetic 
drugs have been conducted to evaluate their effects on 
cancers,  many  of  which  have  shown  promising  results. 
Epigenetic drugs alone or in combination with conventional 
drugs may prove to be a significant advance over the con-
ventional drugs used to treat both acute and delayed SM 
toxicity. Since epigenetic defects are thought to underlie a 
broad range of diseases, the scope of epigenetic therapy is 
likely to expand. At present, the targets for epigenetic drugs 
are DNMTs and HDACs, but since a variety of molecules 
are involved in epigenetic mechanisms, there are several 
other targets as well. 
Collectively,  we  may  speculate  that,  mustards  may 
cause epigenetic perturbations within the affected cells 
and reducing mustard-induced lung toxicity requires gene 
activation  rather  than  gene  silencing.  This  preliminary 
observation warrants future studies to clarify the epigenetic 
perturbations in the pathogenesis of delayed-mustard toxic-
ity. A variety of HDAC inhibitors as well as other epigenetic 
modifiers could give valuable results in experimental stud-
ies and may open new avenues for treatment of SM-induced 
toxicity. 
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